CME Group (CME) Gets a Sell from J.P. Morgan

J.P. Morgan analyst Ken Worthington maintained a Sell rating on CME Group yesterday and set a price target of $271.00. The company’s shares closed yesterday at $287.65.

Claim 30% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Worthington is a 3-star analyst with an average return of 2.1% and a 50.10% success rate. Worthington covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Blackstone Group, and CME Group.

In addition to J.P. Morgan, CME Group also received a Sell from Goldman Sachs’s Alexander Blostein in a report issued on April 8. However, on April 15, Piper Sandler maintained a Buy rating on CME Group (NASDAQ: CME).

Based on CME Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.65 billion and a net profit of $1.17 billion. In comparison, last year the company earned a revenue of $1.53 billion and had a net profit of $874.6 million

Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, Elizabeth Cook, a Director at CME sold 1,000.00 shares for a total of $320,000.00.